Variant report
Variant | nsv963332 |
---|---|
Chromosome Location | chr3:75386915-75387736 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545992777 | chr3:75386932-75386933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190956839 | chr3:75386963-75386964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528543593 | chr3:75387001-75387002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs375100538 | chr3:75387011-75387012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112049502 | chr3:75387030-75387031 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570777480 | chr3:75387069-75387070 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369700300 | chr3:75387070-75387071 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551248766 | chr3:75387098-75387099 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562948361 | chr3:75387115-75387116 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533560278 | chr3:75387134-75387135 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551232915 | chr3:75387190-75387191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566537665 | chr3:75387232-75387233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539174881 | chr3:75387290-75387291 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533574038 | chr3:75387316-75387317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557398179 | chr3:75387326-75387327 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149731239 | chr3:75387330-75387331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116793397 | chr3:75387339-75387340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566898006 | chr3:75387363-75387364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs151106592 | chr3:75387373-75387374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376708557 | chr3:75387383-75387384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141101940 | chr3:75387389-75387390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4677503 | chr3:75387457-75387458 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs556277114 | chr3:75387466-75387467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182655692 | chr3:75387480-75387481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186978041 | chr3:75387489-75387490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149812133 | chr3:75387530-75387531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190684613 | chr3:75387542-75387543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574042455 | chr3:75387561-75387562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182724345 | chr3:75387580-75387581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563192058 | chr3:75387592-75387593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533388241 | chr3:75387609-75387610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189089984 | chr3:75387616-75387617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs193032661 | chr3:75387677-75387678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184562480 | chr3:75387679-75387680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77775238 | chr3:75387701-75387702 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566935537 | chr3:75387715-75387716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537440355 | chr3:75387716-75387717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146861037 | chr3:75387719-75387720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571498701 | chr3:75387728-75387729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Autism | 22102821 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:75381800-75389800 | Weak transcription | Right Atrium | heart |
2 | chr3:75382600-75389800 | Weak transcription | Spleen | Spleen |
3 | chr3:75385800-75387200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr3:75386800-75388000 | Enhancers | GM12878-XiMat | blood |
5 | chr3:75387200-75387400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr3:75387200-75389800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr3:75387400-75389800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |